UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

1150. Evaluating the Impact of Antibiotic Prophylaxis on the Microbiology and Incidence of Ventriculitis in Patients with External Ventricular Drains

Open forum infectious diseases, 2019-10, Vol.6 (Supplement_2), p.S410-S411

2019

Volltextzugriff (PDF)

116. Leveraging the Use of the PCR-based Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Swab in the Emergency Department to Optimize Vancomycin Use in the Inpatient Setting

Open forum infectious diseases, 2020-12, Vol.7 (Supplement_1), p.S72-S72

2020

Volltextzugriff (PDF)

162. Association Between Antibiotic Use and Multidrug-Resistant Organism Detection in Advanced Cancer Patients on Palliative Chemotherapy

Open forum infectious diseases, 2018-11, Vol.5 (suppl_1), p.S14-S15

2018

Volltextzugriff (PDF)

1797. Combining Rapid Diagnostics With Pharmacy Resident-Led Antimicrobial Stewardship to Optimize Outcomes for Bacteremia With Methicillin-Resistant S. aureus (MRSA-B), Methicillin-Susceptible S. aureus (MSSA-B), and Coagulase-Negative Staphylococcus (CoNS) at Yale New Haven Hospital (YNHH)

Open forum infectious diseases, 2018-11, Vol.5 (suppl_1), p.S509-S509

2018

Volltextzugriff (PDF)

1832. Concordance in End-of-Life Antimicrobial Prescribing Practices among Medicine Subspecialists

Open forum infectious diseases, 2018-11, Vol.5 (suppl_1), p.S521-S522

2018

Volltextzugriff (PDF)

195. Reducing Time to Optimal Antimicrobial Therapy (OAT) for Bloodstream Infections (BSI) due to Gram Positive Cocci (GPC) in Chains Using Rapid Diagnostics Paired with Antimicrobial Stewardship (ASP) Efforts

Open forum infectious diseases, 2022-12, Vol.9 (Supplement_2)

2022

Volltextzugriff (PDF)

1980. Efficacy of an Oral Vancomycin Loading Dose (LD) in the Treatment of Confirmed Clostridium Difficile Infection (CDI)

Open forum infectious diseases, 2018-11, Vol.5 (suppl_1), p.S575-S575

2018

Volltextzugriff (PDF)

2385. Evaluating the Antibiotic Risk for Clostridioides difficile Infection (CDI): Comparing Piperacillin/Tazobactam to Cefepime and Ceftazidime

Open forum infectious diseases, 2019-10, Vol.6 (Supplement_2), p.S823-S824

2019

Volltextzugriff (PDF)

2487. Vaccination Rates in Post-Transplant Hematopoietic Stem Cell Transplant (HSCT) Patients: Where Do We Stand?

Open forum infectious diseases, 2018-11, Vol.5 (suppl_1), p.S746-S746

2018

Volltextzugriff (PDF)

2645. Clinical Outcomes of Oseltamivir vs. Baloxavir in Patients Hospitalized with Influenza A

Open forum infectious diseases, 2019-10, Vol.6 (Supplement_2), p.S925-S925

2019

Volltextzugriff (PDF)

2683. Evaluation of the Negative Predictive Value (NPV) of Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Swab Screening in Acute Myeloid Leukemia Patients

Open forum infectious diseases, 2019-10, Vol.6 (Supplement_2), p.S942-S943

2019

Volltextzugriff (PDF)

2688. The Clinical Impact of Early De-escalation of Broad-Spectrum Antibiotics in Acute Myeloid Leukemia Patients with Febrile Neutropenia

Open forum infectious diseases, 2019-10, Vol.6 (Supplement_2), p.S944-S944

2019

Volltextzugriff (PDF)

2694. Incidence of Pneumocytis jiroveci (PJP) Infection with 3-Month Prophylaxis of Aerosolized Pentamidine (AP) in Autologous Hematopoietic Stem Cell Transplantation (HSCT)

Open forum infectious diseases, 2019-10, Vol.6 (Supplement_2), p.S947-S947

2019

Volltextzugriff (PDF)

2737. Real World Evaluation of Antifungal Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant (aHSCT) Patients, Is Routine Antifungal Prophylaxis Needed?

Open forum infectious diseases, 2023-11, Vol.10 (Supplement_2)

2023

Volltextzugriff (PDF)

308. Re-purposing Beta-lactam Antibiotics as Fluoroquinolone Sparing Stepdown Therapy for the Treatment of Enterobacteriales Bloodstream Infections

Open forum infectious diseases, 2020-12, Vol.7 (Supplement_1), p.S151-S152

2020

Volltextzugriff (PDF)

408: EVALUATING LENGTH OF ANTIMICROBIAL THERAPY FOR NECROTIZING SOFT TISSUE INFECTIONS

Critical care medicine, 2023-01, Vol.51 (1), p.190-190

2023

Volltextzugriff (PDF)

574. De-escalation of Broad Spectrum Antibiotics during Cytokine Release Syndrome with Haploidentical Hematopoietic Stem Cell Transplantation

Open forum infectious diseases, 2020-12, Vol.7 (Supplement_1), p.S352-S352

2020

Volltextzugriff (PDF)

577. Incidence and Outcomes of Positive Outpatient Surveillance Blood Cultures in Hematopoietic Stem Cell Transplant (HSCT) Patients with Graft Versus Host Disease (GvHD) On High Dose ≥ 0.5 mg/kg/day (HD) and Low Dose < 0.5mg/kg/day (LD) Steroid Therapy

Open forum infectious diseases, 2020-12, Vol.7 (Supplement_1), p.S353-S354

2020

Volltextzugriff (PDF)

588. A Safety analysis of High Dose Intrawound Vancomycin in Arthroplasty

Open forum infectious diseases, 2022-12, Vol.9 (Supplement_2)

2022

Volltextzugriff (PDF)

589. Clinical Outcomes of Twice versus Thrice daily Metronidazole Dosing for Bacteroides Bloodstream Infections

Open forum infectious diseases, 2022-12, Vol.9 (Supplement_2)

2022

Volltextzugriff (PDF)

650: USE OF NON-CARBAPENEM ANTIBIOTICS AS DEFINITIVE THERAPY FOR ESBL BACTEREMIA

Critical care medicine, 2019-01, Vol.47 (1), p.305-305

2019

Volltextzugriff (PDF)

686: OPTIMIZING THE IDENTIFICATION OF PATIENTS AT RISK FOR RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTIONS

Critical care medicine, 2022-01, Vol.50 (1), p.337-337

2022

Volltextzugriff (PDF)

729. Real World Efficacy of Bezlotoxumab for Prevention of Clostridioides Difficile Recurrence in Immunosuppressed Patients

Open forum infectious diseases, 2020-12, Vol.7 (Supplement_1), p.S415-S415

2020

Volltextzugriff (PDF)

810Voriconazole Dose Modification Guideline to Optimize Therapeutic Levels in Patients With Hematologic Malignancies

Open forum infectious diseases, 2015-12, Vol.2 (suppl_1), p.S236-S236

2015

Volltextzugriff (PDF)

934: UTILIZING THE CARBAPENEM-VALPROIC ACID DRUG INTERACTION IN THE MANAGEMENT OF VALPROIC ACID OVERDOSE

Critical care medicine, 2018-01, Vol.46 (1 Suppl 1), p.450-450

2018

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(87)
Mit Volltextzugriff
(79)

Publikationsform

Sprache

Englisch
(92)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

1150. Evaluating the Impact of Antibiotic Prophylaxis on the Microbiology and Incidence of Ventriculitis in Patients with External Ventricular Drains

116. Leveraging the Use of the PCR-based Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Swab in the Emergency Department to Optimize Vancomycin Use in the Inpatient Setting

162. Association Between Antibiotic Use and Multidrug-Resistant Organism Detection in Advanced Cancer Patients on Palliative Chemotherapy

1797. Combining Rapid Diagnostics With Pharmacy Resident-Led Antimicrobial Stewardship to Optimize Outcomes for Bacteremia With Methicillin-Resistant S. aureus (MRSA-B), Methicillin-Susceptible S. aureus (MSSA-B), and Coagulase-Negative Staphylococcus (CoNS) at Yale New Haven Hospital (YNHH)

1832. Concordance in End-of-Life Antimicrobial Prescribing Practices among Medicine Subspecialists

195. Reducing Time to Optimal Antimicrobial Therapy (OAT) for Bloodstream Infections (BSI) due to Gram Positive Cocci (GPC) in Chains Using Rapid Diagnostics Paired with Antimicrobial Stewardship (ASP) Efforts

1980. Efficacy of an Oral Vancomycin Loading Dose (LD) in the Treatment of Confirmed Clostridium Difficile Infection (CDI)

2385. Evaluating the Antibiotic Risk for Clostridioides difficile Infection (CDI): Comparing Piperacillin/Tazobactam to Cefepime and Ceftazidime

2487. Vaccination Rates in Post-Transplant Hematopoietic Stem Cell Transplant (HSCT) Patients: Where Do We Stand?

2645. Clinical Outcomes of Oseltamivir vs. Baloxavir in Patients Hospitalized with Influenza A

2683. Evaluation of the Negative Predictive Value (NPV) of Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Swab Screening in Acute Myeloid Leukemia Patients

2688. The Clinical Impact of Early De-escalation of Broad-Spectrum Antibiotics in Acute Myeloid Leukemia Patients with Febrile Neutropenia

2694. Incidence of Pneumocytis jiroveci (PJP) Infection with 3-Month Prophylaxis of Aerosolized Pentamidine (AP) in Autologous Hematopoietic Stem Cell Transplantation (HSCT)

2737. Real World Evaluation of Antifungal Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant (aHSCT) Patients, Is Routine Antifungal Prophylaxis Needed?

308. Re-purposing Beta-lactam Antibiotics as Fluoroquinolone Sparing Stepdown Therapy for the Treatment of Enterobacteriales Bloodstream Infections

408: EVALUATING LENGTH OF ANTIMICROBIAL THERAPY FOR NECROTIZING SOFT TISSUE INFECTIONS

574. De-escalation of Broad Spectrum Antibiotics during Cytokine Release Syndrome with Haploidentical Hematopoietic Stem Cell Transplantation

577. Incidence and Outcomes of Positive Outpatient Surveillance Blood Cultures in Hematopoietic Stem Cell Transplant (HSCT) Patients with Graft Versus Host Disease (GvHD) On High Dose ≥ 0.5 mg/kg/day (HD) and Low Dose < 0.5mg/kg/day (LD) Steroid Therapy

588. A Safety analysis of High Dose Intrawound Vancomycin in Arthroplasty

589. Clinical Outcomes of Twice versus Thrice daily Metronidazole Dosing for Bacteroides Bloodstream Infections

650: USE OF NON-CARBAPENEM ANTIBIOTICS AS DEFINITIVE THERAPY FOR ESBL BACTEREMIA

686: OPTIMIZING THE IDENTIFICATION OF PATIENTS AT RISK FOR RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTIONS

729. Real World Efficacy of Bezlotoxumab for Prevention of Clostridioides Difficile Recurrence in Immunosuppressed Patients

810Voriconazole Dose Modification Guideline to Optimize Therapeutic Levels in Patients With Hematologic Malignancies

934: UTILIZING THE CARBAPENEM-VALPROIC ACID DRUG INTERACTION IN THE MANAGEMENT OF VALPROIC ACID OVERDOSE

Suchergebnisse filtern